Quarterly Results

PANACEA BIOTEC LTD.

NSE : PANACEABIOBSE : 531349ISIN CODE : INE922B01023Industry : Pharmaceuticals & DrugsHouse : Soshil Kumar Jain
BSE121.30-2.15 (-1.74 %)
PREV CLOSE ( ) 123.45
OPEN PRICE ( ) 124.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 16279
TODAY'S LOW / HIGH ( )120.35 127.40
52 WK LOW / HIGH ( )107.15 202.2
NSE121.55-1.95 (-1.58 %)
PREV CLOSE( ) 123.50
OPEN PRICE ( ) 123.90
BID PRICE (QTY) 121.55 (5489)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 300190
TODAY'S LOW / HIGH( ) 120.30 127.60
52 WK LOW / HIGH ( )107 202.5
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
Audited
UnAudited
Audited
Net Sales
1505
1430.2
1291.9
1289.3
Total Expenditure
1506.5
1465.8
1395
1346
PBIDT (Excl OI)
-1.5
-35.59
-103.1
-56.7
Other Income
56.8
32.3
60.8
150.6
Operating Profit
55.3
-3.29
-42.3
93.90
Interest
8.5
9.1
10
10.5
Exceptional Items
27.8
27.7
277.4
193.8
PBDT
74.6
15.3
225.1
277.2
Depreciation
91.1
93.1
94.8
95.1
Profit Before Tax
-16.5
-77.8
130.3
182.1
Tax
5.5
5.1
20.5
308.9
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-22
-82.89
109.8
-126.8
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-22
-82.89
109.8
-126.8
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-22
-82.9
109.8
-126.8
Equity Capital
61.3
61.3
61.3
61.3
Face Value (IN RS)
1
1
1
1
Reserves
NA
NA
NA
NA
Calculated EPS
-0.35
-1.35
1.79
-2.06
Calculated EPS (Annualised)
-1.43
-5.40
7.16
-8.27
No of Public Share Holdings
16176880
16176880
16176880
16176880
% of Public Share Holdings
26.41
26.41
26.41
26.41
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
-0.09
-2.48
-7.98
-4.39
PBIDTM%
3.67
-0.23
-3.27
7.28
PBDTM%
4.95
1.06
17.42
21.50
PBTM%
-1.09
-5.43
10.08
14.12
PATM%
-1.46
-5.79
8.49
-9.83
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.